Myla Lai-Goldman, MD
Myla Lai-Goldman has been Executive Vice President, Chief Medical Officer since April 2008. Previously, she had served as Chief Scientific Officer and Medical Director since April 1998. During this period Dr. Lai-Goldman managed the Center for Molecular Biology and Pathology at LabCorp’s Research Triangle Park, NC facility, National Genetics Institute, Inc. in Los Angeles, and Viro-Med Laboratories, Inc. in Minneapolis, MN. She is Board Certified in Anatomic and Clinical Pathology and serves as a member of the Executive Committee of LabCorp. Dr. Lai-Goldman, who holds a medical degree from Columbia University, was named Senior Vice President of LabCorp in 1997 and held the position of Medical Director for the Center for Molecular Biology and Pathology since 1991 (with Roche Biomedical Laboratories (RBL) and subsequently LabCorp).